ZBH Valuation

Zimmer Biomet Holdings Inc

Add to Watchlist

Advanced Chart

96.870

-0.46(-0.473%)1D

Overview
Forecast
Valuation
Earnings

ZBH Relative Valuation

ZBH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ZBH is overvalued; if below, it's undervalued.

Historical Valuation

Zimmer Biomet Holdings Inc (ZBH) is now in the Undervalued zone, suggesting that its current forward PE ratio of 12.04 is considered Undervalued compared with the five-year average of 16.51. The fair price of Zimmer Biomet Holdings Inc (ZBH) is between 142.58 to 178.04 according to relative valuation methord. Compared to the current price of 97.33 USD , Zimmer Biomet Holdings Inc is Undervalued By 31.74%.

Relative Value

Fair Zone

142.58-178.04

Current Price：97.33

31.74%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

1.55

P/B

Median3y

1.92

Median5y

2.11

6.45

FCF Yield

Median3y

4.05

Median5y

3.76

Competitors Valuation Multiple

The average P/S ratio for ZBH's competitors is 3.65, providing a benchmark for relative valuation. Zimmer Biomet Holdings Inc Corp (ZBH) exhibits a P/S ratio of 2.31, which is -36.59% above the industry average. Given its robust revenue growth of 1.05%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

ZBH.N

Zimmer Biomet Holdings Inc

2.31

Average P/S: 3.65

1.05%